Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas A Rando

Showing results (1-10 of 204) with videos related to

Pageof 21
Sort By:
The New England Journal of Medicine|September 17, 2004
Artificial sweeteners--enhancing glycosylation to treat muscular dystrophiesThomas A Rando
Cell Stem Cell|September 13, 2008
Turning back time: reversing tissue pathology to enhance stem cell engraftmentThomas A Rando
Cell|July 3, 2007
The immortal strand hypothesis: segregation and reconstructionThomas A Rando
American Journal of Physical Medicine & Rehabilitation|April 9, 2026
Exercise as A Biological Driver of Skeletal Muscle Regeneration and Repair: Implications for Regenerative RehabilitationThomas A Rando
American Journal of Physical Medicine & Rehabilitation|November 1, 2002
Oxidative stress and the pathogenesis of muscular dystrophiesThomas A Rando
Nature Biotechnology|March 8, 2017
Fleeting factors, turning back timeThomas A Rando
Current Opinion in Neurology|August 16, 2012
Recent advances in the pathogenesis and treatment of neuromuscular diseasesThomas A Rando
The Lancet. Neurology|February 16, 2008
Get personal with gene therapy for muscular dystrophyThomas A Rando
Annals of Neurology|July 25, 2006
Prognostic value of telomere length: the long and short of itThomas A Rando
Biochimica Et Biophysica Acta|September 29, 2006
Non-viral gene therapy for Duchenne muscular dystrophy: progress and challengesThomas A Rando
Pageof 21

Showing results (1-10 of 204) with videos related to

Sort By:
Pageof 21
The New England Journal of Medicine|September 17, 2004
Artificial sweeteners--enhancing glycosylation to treat muscular dystrophiesThomas A Rando
Cell Stem Cell|September 13, 2008
Turning back time: reversing tissue pathology to enhance stem cell engraftmentThomas A Rando
Cell|July 3, 2007
The immortal strand hypothesis: segregation and reconstructionThomas A Rando
American Journal of Physical Medicine & Rehabilitation|April 9, 2026
Exercise as A Biological Driver of Skeletal Muscle Regeneration and Repair: Implications for Regenerative RehabilitationThomas A Rando
American Journal of Physical Medicine & Rehabilitation|November 1, 2002
Oxidative stress and the pathogenesis of muscular dystrophiesThomas A Rando
Nature Biotechnology|March 8, 2017
Fleeting factors, turning back timeThomas A Rando
Current Opinion in Neurology|August 16, 2012
Recent advances in the pathogenesis and treatment of neuromuscular diseasesThomas A Rando
The Lancet. Neurology|February 16, 2008
Get personal with gene therapy for muscular dystrophyThomas A Rando
Annals of Neurology|July 25, 2006
Prognostic value of telomere length: the long and short of itThomas A Rando
Biochimica Et Biophysica Acta|September 29, 2006
Non-viral gene therapy for Duchenne muscular dystrophy: progress and challengesThomas A Rando
Pageof 21